Fine Gestion

Eli Lilly has turned its numbers around and become the world's most valuable pharma company, thanks to its type 2 diabetes and off-label use obesity drug tiride, which generated no less than USD 1.4 billion in its first full quarter on the market.

Eli Lilly: From Struggling to Trillion-Dollar Pharma Success

The US Food and Drug Administration (FDA) has approved a new treatment for patients with acute leukaemia and lymphoma who have failed to respond to other therapies.

Eli Lilly's Jaypirca Approved in US for Leukaemia and Lymphoma Treatment

Solution seeks to reach banks that want to bring this type of asset in their applications to clients that are not yet experts in this world

With an eye on FOMO, Matera and Liqi partner to offer cryptocurrency trading platform

OVHcloud, a leading provider of high-performance cloud infrastructure, has announced a collaboration with Bware Labs, a leading developer of Blockchain APIs.

Bware Labs and OVHcloud Join Forces for Lightning-Fast Blockchain API Platform


Rome - The end of November and the beginning of December are expected to be freezing in Europe, with a wave of cold and snow that persists until the Immaculate Conception. This...

Intense Cold and Rainfall

Eli Lilly have announced the appointment of Olivia Burston as Senior IT Business Analyst - MES.

Eli Lilly appoints Olivia Burston to Senior IT Business Analyst - MES

Alexandria Real Estate Equities, Inc., a leading owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses, has announced an exclusive partnership with Eli Lilly and Company to expand Lilly's innovative Gateway Labs model to the San Diego life science cluster.

Alexandria Real Estate Equities and Lilly Partner to Expand Gateway Labs in San Diego

A Senior Consultant - Controle de Gestion has announced their departure from GRANT THORNTON France. Emna Mezghani leaves to join Thomson Broadcast as Responsable du contrôle de gestion.

GRANT THORNTON France loses Senior Consultant - Controle de Gestion to Thomson Broadcast

Believe and Time Records renew their agreement: the joint adventure between an absolute leader in the field of global digital music distribution and one of the most fascinating and atypical stories of

Believe and Time Records renew their agreement

The drug “Mounjaro” could soon be approved in the EU for obesity treatment. A new plant is to be built in Rhineland-Palatinate as an investment of billions for this purpose.

Select a company within accounting within les ulis